ascendis pharma glp-1 receptor agonist medications Emerging Trends in the Development of GLP-1 Receptor Agonists Upcoming wave of hormone-based therapies

[DOI] [PubMed] [Google Scholar] [16].Naslund E, Barkeling B, King N, Gutniak M, Blundell JE, Holst JJ, Rossner S, Hellstrom PM, Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men, Int J Obes Relat Metab Disord, 23 (1999) 304311

[Google Scholar] 80.Li Z., et al

Gender-specific risk factors for incident sarcopenia: 8-year follow-up of the English longitudinal study of ageing

Some other risk factors include starting treatment too quickly or increasing the dose faster than recommended

Market Report Scope GLP-1 Receptor Agonist Market Report Coverage Uncover macros and micros vetted on 75+ parameters: Get instant access to report GLP-1 Receptor Agonist Industry News In July 2025, PolyPid Ltd